Here are the key takeaways from the full Times Magazine story about the F.D.A.: The F.D.A.’s regulators have an enormous ...

Unlike Drs. Adam Cifu and John Mandrola, I do not constantly boast of my "nuance" or claim to be a master of "clinical appraisal." They have so much to teach me.

Jeneen Interlandi, a domestic correspondent for Opinion and a staff writer at the magazine, writes frequently about public health. For this article, she interviewed dozens of people who have worked ...

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...

The U.S. Food and Drug Administration (FDA) announced on June 18, 2025, the release of its proposed method for ranking ...

Deputy Jacob Lewis and Gambit, Chelan County's drug-sniffing border collie, are no longer working at the county jail. Gambit ...

Imagion Biosystems receives positive feedback from US FDA for HER2 breast cancer phase II clinical trial. ... Read More The ...

The FDA has approved garadacimab-gxii for prophylactic use in patients aged 12 years and older with hereditary angioedema, ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...

Make your portfolio income-producing and provide valuable cash for your daily life. Read more on how to turn your portfolio ...

From FDA approvals streamlining access to critical therapies to new breakthroughs in challenging malignancies, the field of ...